Biopharma Business

Tag "EPFL"

Anti-cancer drug gets a boost when combined with antirheumatic

Scientists at EPFL and NTU have discovered that combining an anticancer drug with an antirheumatic produces improved effects against tumors. The discovery opens a new path for drug-drug synergy. One

Read Full Article

Upcoming Events


The Magazine

New Subscriber

Subscribe Here